US5166057A
(en)
†
|
1989-08-28 |
1992-11-24 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Recombinant negative strand rna virus expression-systems
|
US6887699B1
(en)
|
1990-05-22 |
2005-05-03 |
Medimmune Vaccines, Inc. |
Recombinant negative strand RNA virus expression systems and vaccines
|
US20030054505A1
(en)
|
1997-09-26 |
2003-03-20 |
Hong Jin |
Recombinant rsv expression systems and vaccines
|
US7465574B2
(en)
*
|
1994-09-30 |
2008-12-16 |
Medimmune, Llc |
Recombinant RSV virus expression systems and vaccines
|
US20050287540A1
(en)
*
|
1995-09-27 |
2005-12-29 |
Murphy Brian R |
Production of attenuated negative stranded RNA virus vaccines from cloned nucleotide sequences
|
US6923971B2
(en)
*
|
1995-09-27 |
2005-08-02 |
The United States Of America As Represented By The Department Of Health & Human Services |
Respiratory syncytial virus vaccines expressing protective antigens from promoter-proximal genes
|
US7485440B2
(en)
|
1995-09-27 |
2009-02-03 |
The United States Of America As Represented By The Department Of Health And Human Services |
Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2
|
US6689367B1
(en)
|
1995-09-27 |
2004-02-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences
|
US7846455B2
(en)
|
1996-07-15 |
2010-12-07 |
The United States Of America As Represented By The Department Of Health And Human Services |
Attenuated chimeric respiratory syncytial virus
|
AU2004205289B2
(en)
*
|
1996-07-15 |
2008-04-17 |
The Government Of The United States Of America, Represented By The Department Of Health And Human Services |
Production of attenuated respiratory sincytial virus vaccines from cloned nucleotide sequences
|
JP4413999B2
(ja)
|
1996-07-15 |
2010-02-10 |
アメリカ合衆国 |
クローニングされたヌクレオチド配列からの弱毒化呼吸シンシチウムウィルスワクチンの製造
|
US6699476B1
(en)
|
1996-07-15 |
2004-03-02 |
Peter L. Collins |
Production of recombinant respiratory syncytial viruses expressing immune modulatory molecules
|
US6596529B1
(en)
*
|
1997-05-02 |
2003-07-22 |
Uab Research Foundation |
Manipulation of negative stranded RNA viruses by rearrangement of their genes and uses thereof
|
US7250171B1
(en)
*
|
1997-05-23 |
2007-07-31 |
United States Of America As Represented By The Dept. Of Health & Human Services |
Construction and use of recombinant parainfluenza viruses expressing a chimeric glycoprotein
|
US7201907B1
(en)
*
|
1997-05-23 |
2007-04-10 |
The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Attenuated human-bovine chimeric parainfluenza virus(PIV) vaccines
|
US6410023B1
(en)
|
1997-05-23 |
2002-06-25 |
United States Of America |
Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of a non-essential gene
|
US20030082209A1
(en)
*
|
2000-07-05 |
2003-05-01 |
Skiadopoulos Mario H. |
Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines
|
US7951383B2
(en)
*
|
1997-05-23 |
2011-05-31 |
The United States Of America As Represented By The Department Of Health And Human Services |
Attenuated parainfluenza virus (PIV) vaccines
|
US7192593B2
(en)
*
|
1997-05-23 |
2007-03-20 |
The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogens
|
US7632508B2
(en)
|
1997-05-23 |
2009-12-15 |
The United States Of America |
Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines
|
US7314631B1
(en)
*
|
1997-05-23 |
2008-01-01 |
The United States Of America As Represented By The Department Of Health And Human Services |
Use of recombinant live-attenuated parainfluenza virus (PIV) as a vector to protect against disease caused by PIV and respiratory syncytial virus (RSV)
|
FR2764903A1
(fr)
*
|
1997-06-23 |
1998-12-24 |
Pasteur Institut |
Detection des infections par des paramyxovirus (virus respiratoire syncitial et virus parainfluenza) utilisant des polynucleotides codant de la proteine l
|
US7662397B2
(en)
*
|
1997-07-15 |
2010-02-16 |
The United States Of America As Represented By The Department Of Health And Human Services |
Respiratory syncytial virus vaccines expressing protective antigens from promoter-proximal genes
|
US20040005542A1
(en)
*
|
2001-06-22 |
2004-01-08 |
Krempl Christine D |
Respiratory syncytial virus vaccines expressing protective antigens from promotor- proximal genes
|
US20100028377A1
(en)
*
|
1997-09-26 |
2010-02-04 |
Medimmune, Llc |
Recombinant RSV Virus Expression Systems And Vaccines
|
US6830748B1
(en)
|
1997-09-26 |
2004-12-14 |
Medimmune Vaccines, Inc. |
Recombinant RSV virus expression systems and vaccines
|
BR9910929A
(pt)
|
1998-06-03 |
2001-02-20 |
American Cyanamid Co |
Processo para produzir um vìrus mononegavirales recombinante, vìrus recombinante, e, composição
|
ATE384126T1
(de)
|
1998-06-12 |
2008-02-15 |
Sinai School Medicine |
Interferon induzierende genetisch veränderte attenuierte viren
|
KR20060080249A
(ko)
|
1998-06-12 |
2006-07-07 |
마운트 시나이 스쿨 오브 메디신 오브 뉴욕 유니버시티 |
변형된 인터페론 길항물질을 보유하고, 백신 및 약제로사용되는 약독화된 네거티브 가닥 바이러스
|
US6544785B1
(en)
|
1998-09-14 |
2003-04-08 |
Mount Sinai School Of Medicine Of New York University |
Helper-free rescue of recombinant negative strand RNA viruses
|
US6146642A
(en)
|
1998-09-14 |
2000-11-14 |
Mount Sinai School Of Medicine, Of The City University Of New York |
Recombinant new castle disease virus RNA expression systems and vaccines
|
IL144084A0
(en)
*
|
1999-02-03 |
2002-05-23 |
Biosante Pharmaceuticals Inc |
Therapeutic calcium phosphate particles and methods of manufacture and use
|
CN100491530C
(zh)
|
1999-04-13 |
2009-05-27 |
美国政府健康及人类服务部 |
从克隆的核苷酸序列制备减毒嵌合呼吸道合胞病毒疫苗
|
CN100354425C
(zh)
*
|
1999-07-09 |
2007-12-12 |
美国政府健康及人类服务部 |
减毒的人-牛嵌合呼吸道合胞病毒疫苗的生产
|
US7820182B2
(en)
*
|
1999-07-09 |
2010-10-26 |
The United States Of America As Represented By The Department Of Health And Human Services |
Production of attenuated, human-bovine chimeric respiratory syncytial viruses for use in immunogenic compositions
|
MXPA02000490A
(es)
*
|
1999-07-13 |
2004-09-27 |
Us Gov Health & Human Serv |
Produccion de virus sincitiales respiratorios recombinantes, que expresan moleculas inmunomoduladoras.
|
US6586411B1
(en)
|
2000-08-16 |
2003-07-01 |
Mayo Foundation For Medical Education And Research |
System for monitoring the location of transgenes
|
AU7607900A
(en)
*
|
1999-09-22 |
2001-04-24 |
Mayo Foundation For Medical Education And Research |
Therapeutic methods and compositions using viruses of the recombinant paramyxoviridae family
|
US6896881B1
(en)
|
1999-09-24 |
2005-05-24 |
Mayo Foundation For Medical Education And Research |
Therapeutic methods and compositions using viruses of the recombinant paramyxoviridae family
|
US6764685B1
(en)
|
2000-03-21 |
2004-07-20 |
Medimmune Vaccines, Inc. |
Recombinant parainfluenza virus expression systems and vaccines
|
US6635416B2
(en)
|
2000-04-10 |
2003-10-21 |
Mount Sinai School Of Medicine Of New York University |
Screening methods for identifying viral proteins with interferon antagonizing functions and potential antiviral agents
|
US7361496B1
(en)
|
2000-08-02 |
2008-04-22 |
Wyeth |
Rescue of mumps virus from cDNA
|
US7118740B1
(en)
|
2000-09-22 |
2006-10-10 |
Mayo Foundation For Medical Education And Research |
Method for limiting the growth of cancer cells using an attenuated measles virus
|
WO2002044334A2
(en)
*
|
2000-11-28 |
2002-06-06 |
Aviron, Inc. |
Recombinant rsv virus expression systems and vaccines
|
WO2002057302A2
(en)
|
2001-01-19 |
2002-07-25 |
Vironovative B.V. |
A virus causing respiratory tract illness in susceptible mammals
|
US8715922B2
(en)
|
2001-01-19 |
2014-05-06 |
ViroNovative |
Virus causing respiratory tract illness in susceptible mammals
|
UA82466C2
(uk)
*
|
2001-07-18 |
2008-04-25 |
Бавариан Нордика А/С |
Спосіб посилення ампліфікації хордопоксвірусу
|
CA2466020A1
(en)
*
|
2001-09-28 |
2003-04-10 |
University Of South Florida |
Rsv gene expression vaccine
|
EP1438399A4
(en)
*
|
2001-09-28 |
2005-09-14 |
Univ North Carolina |
PARAMYXOVIRUSES AS GENE TRANSFER VECTORS TO PULMONARY CELLS
|
JP4553589B2
(ja)
|
2002-02-21 |
2010-09-29 |
メディミューン,エルエルシー |
組換えパラインフルエンザウイルス発現系とメタニューモウイルスから得られる異種抗原を含むワクチン
|
US7465456B2
(en)
|
2002-04-26 |
2008-12-16 |
Medimmune, Llc |
Multi plasmid system for the production of influenza virus
|
ES2526191T3
(es)
|
2002-04-26 |
2015-01-08 |
Medimmune, Llc |
Método para producir virus influenza B infeccioso en cultivo celular
|
JP4549188B2
(ja)
|
2002-09-18 |
2010-09-22 |
アメリカ合衆国 |
組換えヒト2型パラインフルエンザウイルス(HPIV2)のcDNAからの回収(recovery)、並びにPIVおよび他のヒト病原体に対する免疫応答を誘発する免疫原性組成物における、そしてベクターとしての組換えHPIV2の使用
|
WO2004028478A2
(en)
*
|
2002-09-27 |
2004-04-08 |
Medimmune Vaccines, Inc. |
Functional mutations in respiratory syncytial virus
|
AU2003261405A1
(en)
*
|
2002-11-01 |
2004-06-07 |
University Of Massachusetts |
Regulation of transcription elongation factors
|
US6605283B1
(en)
|
2002-11-01 |
2003-08-12 |
The United States Of America As Represented By The Secretary Of Agriculture |
Nucleotide sequence for the Avian Metapneumovirus (Colorado) attachment glycoprotein gene
|
WO2005014626A2
(en)
|
2003-02-28 |
2005-02-17 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Recombinant human metapneumovirus and its use
|
CA2523319A1
(en)
|
2003-04-25 |
2004-11-11 |
Medimmune Vaccines, Inc. |
Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus
|
EP1633860A2
(en)
|
2003-06-09 |
2006-03-15 |
Wyeth |
IMPROVED METHOD FOR THE RECOVERY OF NON-SEGMENTED, NEGATIVE-STRANDED RNA VIRUSES FROM cDNA
|
EP1633312A4
(en)
|
2003-06-16 |
2012-09-26 |
Medimmune Llc |
INFLUENZA HEMAGGLUTININE AND NEURAMINIDASE VARIANTS
|
JP4771959B2
(ja)
|
2003-12-23 |
2011-09-14 |
メディミューン,エルエルシー |
インフルエンザウイルス作製のための多重プラスミド系
|
EP2500419B1
(en)
|
2003-12-24 |
2018-03-21 |
De Staat der Nederlanden, vert. door de minister van VWS |
A respiratory syncytial virus with a genomic deficiency complemented in trans
|
US7527800B2
(en)
|
2004-05-25 |
2009-05-05 |
Medimmune, Llc |
Influenza hemagglutinin and neuraminidase variants
|
CA2610632C
(en)
|
2004-06-01 |
2022-10-04 |
Mount Sinai School Of Medicine Of New York University |
Genetically engineered swine influenza virus and uses thereof
|
EP1828421A2
(en)
*
|
2004-11-16 |
2007-09-05 |
Janssen Pharmaceutica N.V. |
Sphingosine kinase-1 mediates gene expression regulation of a monocyte chemoattractant protein-1 gene
|
JP2006202269A
(ja)
|
2004-12-22 |
2006-08-03 |
Canon Inc |
情報処理装置、情報処理装置の制御方法およびそのプログラム、記憶媒体
|
US8137676B2
(en)
|
2005-02-15 |
2012-03-20 |
Mount Sinai School Of Medicine |
Genetically engineered equine influenza virus and uses thereof
|
WO2006098901A2
(en)
|
2005-03-08 |
2006-09-21 |
Medimmune Vaccines, Inc. |
Influenza hemagglutinin and neuraminidase variants
|
US7790434B2
(en)
|
2005-06-21 |
2010-09-07 |
Medimmune, Llc |
Methods and compositions for expressing negative-sense viral RNA in canine cells
|
AU2006262380A1
(en)
|
2005-06-21 |
2007-01-04 |
Medimmune, Llc |
Methods and compositions for expressing a heterologous protease
|
PT2529747T
(pt)
|
2005-12-02 |
2018-05-09 |
Icahn School Med Mount Sinai |
Vírus da doença de newcastle quiméricos que apresentam proteínas de superfície não nativas e suas utilizações
|
CN101405389A
(zh)
*
|
2006-01-17 |
2009-04-08 |
生物载体株式会社 |
新型蛋白质表达系统
|
WO2007124327A2
(en)
|
2006-04-19 |
2007-11-01 |
Medimmune Llc. |
Methods and compositions for expressing negative-sense viral rna in canine cells
|
EP2049662A4
(en)
|
2006-07-21 |
2009-12-30 |
Medimmune Llc |
METHODS AND COMPOSITIONS FOR INCREASING REPLICATION CAPACITY OF A FLU VIRUS
|
KR101586971B1
(ko)
|
2006-08-09 |
2016-02-22 |
메디뮨 엘엘씨 |
인플루엔자 헤마글루티닌 및 뉴라미니다제 변이체
|
ES2523587T3
(es)
|
2007-06-18 |
2014-11-27 |
Medimmune, Llc |
Virus influenza B que tienen alteraciones en el polipéptido hemaglutinina
|
EP2069485A4
(en)
*
|
2007-07-13 |
2011-05-25 |
Medimmune Llc |
PREPARATION OF NEGATIVE STRAND RNA VIRUSES BY ELECTROPORATION
|
AU2009251328B2
(en)
|
2008-05-30 |
2014-10-02 |
Glycofi, Inc. |
Yeast strain for the production of proteins with terminal alpha-1,3-linked galactose
|
EP2313428A2
(en)
*
|
2008-07-01 |
2011-04-27 |
The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services |
Recombinant human parainfluenza type 1 viruses (hpiv1s) containing mutations in or deletion of the c protein are attenuated in african green monkeys and in ciliated human airway epithelial cells and are potential vaccine candidates for hpiv1
|
RU2523587C2
(ru)
|
2008-07-11 |
2014-07-20 |
МЕДИММЬЮН, ЭлЭлСи |
Варианты гемагглютинина и нейрамидазы вируса гриппа
|
ES2550179T3
(es)
|
2009-02-05 |
2015-11-05 |
Icahn School Of Medicine At Mount Sinai |
Virus quiméricos de la enfermedad de Newcastle y usos de los mismos
|
AU2010213966B2
(en)
|
2009-02-12 |
2015-01-22 |
Medimmune, Llc |
Influenza hemagglutinin and neuraminidase variants
|
WO2010117786A1
(en)
|
2009-03-30 |
2010-10-14 |
Mount Sinai School Of Medicine Of New York University |
Influenza virus vaccines and uses thereof
|
WO2011014504A1
(en)
|
2009-07-27 |
2011-02-03 |
Mount Sinai School Of Medicine Of New York University |
Recombinant influenza virus vectors and uses thereof
|
US8828406B2
(en)
|
2009-07-30 |
2014-09-09 |
Icahn School Of Medicine At Mount Sinai |
Influenza viruses and uses thereof
|
EP3248615A1
(en)
|
2010-03-30 |
2017-11-29 |
Mount Sinai School of Medicine of New York University |
Influenza virus vaccines and uses thereof
|
HRP20221522T1
(hr)
*
|
2010-07-06 |
2023-02-17 |
Glaxosmithkline Biologicals S.A. |
Čestice za dostavljanje nalik virionu za samo-replicirajuće rna molekule
|
AU2011276234B2
(en)
|
2010-07-06 |
2016-02-25 |
Glaxosmithkline Biologicals S.A. |
Liposomes with lipids having an advantageous pKa- value for RNA delivery
|
US9770463B2
(en)
|
2010-07-06 |
2017-09-26 |
Glaxosmithkline Biologicals Sa |
Delivery of RNA to different cell types
|
WO2012006377A2
(en)
|
2010-07-06 |
2012-01-12 |
Novartis Ag |
Delivery of rna to trigger multiple immune pathways
|
PL2591114T3
(pl)
|
2010-07-06 |
2017-08-31 |
Glaxosmithkline Biologicals Sa |
Immunizacja dużych ssaków małymi dawkami rna
|
WO2012021730A2
(en)
|
2010-08-11 |
2012-02-16 |
Genvec, Inc. |
Respiratory syncytial virus (rsv) vaccine
|
ES2935542T3
(es)
*
|
2010-08-31 |
2023-03-07 |
Glaxosmithkline Biologicals Sa |
Liposomas pequeños para la administración de ARN que codifica para inmunógeno
|
EP3970742B1
(en)
*
|
2010-08-31 |
2022-05-25 |
GlaxoSmithKline Biologicals S.A. |
Pegylated liposomes for delivery of immunogen-encoding rna
|
US9428736B2
(en)
|
2010-09-02 |
2016-08-30 |
Mayo Foundation For Medical Education And Research |
Vesicular stomatitis viruses
|
US9951117B2
(en)
|
2010-09-02 |
2018-04-24 |
Mayo Foundation For Medical Education And Research |
Vesicular stomatitis viruses
|
EP3520813B1
(en)
|
2010-10-11 |
2023-04-19 |
GlaxoSmithKline Biologicals S.A. |
Antigen delivery platforms
|
US10227569B2
(en)
|
2011-04-12 |
2019-03-12 |
Emory University |
Respiratory syncytial virus expression vectors
|
CA2840989A1
(en)
|
2011-07-06 |
2013-01-10 |
Novartis Ag |
Immunogenic combination compositions and uses thereof
|
EP2758075B1
(en)
|
2011-09-20 |
2023-05-03 |
Icahn School of Medicine at Mount Sinai |
Influenza virus vaccines and uses thereof
|
WO2013052859A2
(en)
|
2011-10-05 |
2013-04-11 |
Genvec, Inc. |
Adenoviral vector-based respiratory syncytial virus (rsv) vaccine
|
BR112015014482A2
(pt)
|
2012-12-18 |
2017-11-21 |
Icahn School Med Mount Sinai |
vacinas para vírus influenza e seus usos
|
WO2014159960A1
(en)
|
2013-03-14 |
2014-10-02 |
Icahn School Of Medicine At Mount Sinai |
Antibodies against influenza virus hemagglutinin and uses thereof
|
CA2905272A1
(en)
|
2013-03-14 |
2014-10-02 |
Icahn School Of Medicine At Mount Sinai |
Newcastle disease viruses and uses thereof
|
EP3798310A1
(en)
|
2013-03-14 |
2021-03-31 |
Emory University |
Recombinant rsv with silent mutations, vaccines, and methods related thereto
|
JP6857498B2
(ja)
|
2014-02-27 |
2021-04-14 |
メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. |
癌を処置するための併用方法
|
WO2016118937A1
(en)
|
2015-01-23 |
2016-07-28 |
Icahn School Of Medicine At Mount Sinai |
Influenza virus vaccination regimens
|
MX2017010908A
(es)
|
2015-02-26 |
2017-12-07 |
Boehringer Ingelheim Vetmedica Gmbh |
Vacuna bivalente contra el virus de gripe porcina.
|
US10548966B2
(en)
|
2015-08-20 |
2020-02-04 |
University Of Rochester |
Single-cycle virus for the development of canine influenza vaccines
|
AU2016308917A1
(en)
|
2015-08-20 |
2018-03-15 |
Cornell University |
Live-attenuated vaccine having mutations in viral polymerase for the treatment and prevention of canine influenza virus
|
US10973903B2
(en)
|
2015-08-20 |
2021-04-13 |
University Of Rochester |
NS1 truncated virus for the development of canine influenza vaccines
|
EP3368547A4
(en)
|
2015-10-29 |
2019-06-05 |
Emory University |
RSV CHIMERIC VIRUSES, IMMUNOGENIC COMPOSITIONS AND METHODS OF USE
|
CN109310752B
(zh)
|
2015-12-11 |
2022-12-16 |
美利坚合众国-由健康及人类服务部部长代表 |
提供一系列减毒表型的在m2-2 orf中具有突变的重组呼吸道合胞病毒株
|
WO2017100756A1
(en)
|
2015-12-11 |
2017-06-15 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Recombinant respiratory syncytial virus strains comprising ns1 and ns2 gene shifts
|
WO2017210528A1
(en)
|
2016-06-03 |
2017-12-07 |
University Of Rochester |
Equine influenza virus live-attenuated vaccines
|
JP7237344B2
(ja)
|
2016-06-15 |
2023-03-13 |
アイカーン スクール オブ メディシン アット マウント サイナイ |
インフルエンザウイルス血球凝集素タンパク質及びその使用
|
JP7198759B2
(ja)
|
2016-09-23 |
2023-01-04 |
ザ・ユナイテッド・ステイツ・オブ・アメリカ・アズ・リプリゼンテッド・バイ・ザ・セクレタリー・デパートメント・オブ・ヘルス・アンド・ヒューマン・サービシーズ |
弱毒化表現型を有するヒト呼吸器多核体ウイルス(rsv)のためのワクチン候補
|
EP3606555A4
(en)
|
2017-04-07 |
2021-08-04 |
Icahn School of Medicine at Mount Sinai |
INFLUENZA VIRUS TYPE B ANTI-NEURAMINIDASE ANTIBODIES AND THEIR USES
|
JOP20190256A1
(ar)
|
2017-05-12 |
2019-10-28 |
Icahn School Med Mount Sinai |
فيروسات داء نيوكاسل واستخداماتها
|
US11576963B2
(en)
|
2018-02-27 |
2023-02-14 |
University Of Rochester |
Multivalent live-attenuated influenza vaccine for prevention and control of equine influenza virus (EIV) in horses
|
US11166996B2
(en)
|
2018-12-12 |
2021-11-09 |
Flagship Pioneering Innovations V, Inc. |
Anellovirus compositions and methods of use
|
BR112021016182A2
(pt)
|
2019-02-27 |
2021-11-03 |
Univ Kentucky Res Found |
Composição imunológica multivalente, e, método para induzir uma resposta imune contra uma pluralidade de vírus da influenza equina
|
EP4149956A1
(en)
|
2020-05-13 |
2023-03-22 |
The United States of America, as represented by the Secretary, Department of Health and Human Services |
Rsv vaccine bearing one or more p gene mutations
|
BR112022024539A2
(pt)
|
2020-06-05 |
2022-12-27 |
Us Health |
Vírus sincicial respiratório vivo atenuado
|